December 13, 2024 - 03:24

An intense struggle has unfolded in Washington between companies and officials over where to draw the line on selling technology to China. As tensions between the U.S. and China escalate, American firms are finding themselves at a crossroads, navigating the complex landscape of government regulations and market demands.
In recent months, the U.S. government has ramped up efforts to restrict the flow of sensitive technology to China, citing national security concerns. This has led to significant pushback from businesses that rely on the Chinese market for revenue. Companies argue that excessive restrictions could hinder innovation and competitiveness in the global marketplace.
Executives have been actively lobbying for more lenient policies, emphasizing the importance of maintaining strong trade relations with one of the largest economies in the world. The outcome of this struggle could have far-reaching implications for the tech industry, shaping the future of U.S.-China relations and the global economy. As the debate continues, the stakes remain high for both sides.
May 25, 2026 - 23:35
Pope calls for AI regulation, using technology for common good rather than profitPope Leo XIV issued a powerful call for global regulation of artificial intelligence on Monday, urging developers and governments to prioritize the common good over corporate profits. In a...
May 25, 2026 - 07:17
ANT Systems Launches Industrial-Scale Production of Drought Technology Used on Five ContinentsISTANBUL, Türkiye -- Agricultural nano-technology company ANT Systems has announced the start of industrial-scale production of NANOTERN, a biodegradable water-retention material made from...
May 24, 2026 - 23:42
POET Technologies: Great Technology, Terrible InvestmentPOET Technologies, once a high-flying name in the photonics space, has been handed a Sell rating by analysts who see little near-term payoff for investors. The core issue is a stark mismatch...
May 24, 2026 - 04:15
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the BunchThe first quarter earnings season has now drawn to a close for the healthcare technology for providers sector, and the results paint a clear picture of which companies are thriving and which are...